These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. [Recent Advances in Understanding Colorectal Cancer and Dysplasia Related to Ulcerative Colitis]. Yang DH Korean J Gastroenterol; 2015 Dec; 66(6):312-9. PubMed ID: 26691188 [TBL] [Abstract][Full Text] [Related]
46. Ulcerative colitis neoplasia is not associated with common inflammatory bowel disease single-nucleotide polymorphisms. Connelly TM; Berg AS; Harris LR; Brinton DL; Hegarty JP; Deiling SM; Stewart DB; Koltun WA Surgery; 2014 Aug; 156(2):253-62. PubMed ID: 24947639 [TBL] [Abstract][Full Text] [Related]
47. Random biopsies during surveillance colonoscopy increase dysplasia detection in patients with primary sclerosing cholangitis and ulcerative colitis. Navaneethan U; Kochhar G; Venkatesh PG; Bennett AE; Rizk M; Shen B; Kiran RP J Crohns Colitis; 2013 Dec; 7(12):974-81. PubMed ID: 23523416 [TBL] [Abstract][Full Text] [Related]
48. Family History Associates With Increased Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases. Samadder NJ; Valentine JF; Guthery S; Singh H; Bernstein CN; Leighton JA; Wan Y; Wong J; Boucher K; Pappas L; Rowe K; Burt RW; Curtin K; Smith KR Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1807-1813.e1. PubMed ID: 30267862 [TBL] [Abstract][Full Text] [Related]
49. Inflammatory bowel disease with primary sclerosing cholangitis: A Danish population-based cohort study 1977-2011. Sørensen JØ; Nielsen OH; Andersson M; Ainsworth MA; Ytting H; Bélard E; Jess T Liver Int; 2018 Mar; 38(3):532-541. PubMed ID: 28796371 [TBL] [Abstract][Full Text] [Related]
50. Patients' knowledge and fear of colorectal cancer risk in inflammatory bowel disease. Lopez A; Collet-Fenetrier B; Belle A; Peyrin-Biroulet L J Dig Dis; 2016 Jun; 17(6):383-91. PubMed ID: 27129893 [TBL] [Abstract][Full Text] [Related]
51. Hereditary Colorectal Cancer Syndromes and Inflammatory Bowel Diseases: an ECCO CONFER Multicentre Case Series. Barberio B; Savarino E; Verstockt B; Fumery M; Pugliese D; Bertani L; Buda A; Dragoni G; Goren I; Laish I; Spinelli A; Teich N; Truyens M; Ellul P J Crohns Colitis; 2022 Dec; 16(12):1845-1852. PubMed ID: 35771951 [TBL] [Abstract][Full Text] [Related]
52. [PSC-IBD: specific phenotype of inflammatory bowel disease associated with primary sclerosing cholangitis]. Bajer L; Wohl P; Drastich P Vnitr Lek; 2018; 64(6):659-664. PubMed ID: 30223664 [TBL] [Abstract][Full Text] [Related]
53. Epidemiology of Colorectal Cancer in Inflammatory Bowel Disease - the Evolving Landscape. Linson EA; Hanauer SB Curr Gastroenterol Rep; 2021 Aug; 23(9):16. PubMed ID: 34338892 [TBL] [Abstract][Full Text] [Related]
54. Colon cancer in inflammatory bowel disease: recent trends, questions and answers. Viennot S; Deleporte A; Moussata D; Nancey S; Flourié B; Reimund JM Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S190-201. PubMed ID: 20117342 [TBL] [Abstract][Full Text] [Related]
55. Incidence of colorectal cancer after liver transplantation for primary sclerosing cholangitis: a systematic review and meta-analysis. Singh S; Edakkanambeth Varayil J; Loftus EV; Talwalkar JA Liver Transpl; 2013 Dec; 19(12):1361-9. PubMed ID: 24019127 [TBL] [Abstract][Full Text] [Related]
56. Cancer in inflammatory bowel disease. Xie J; Itzkowitz SH World J Gastroenterol; 2008 Jan; 14(3):378-89. PubMed ID: 18200660 [TBL] [Abstract][Full Text] [Related]